• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

1985 - 2004年英国内脏利什曼病的变化模式

Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004.

作者信息

Malik Aeesha N J, John Lawrence, Bruceson Anthony D M, Lockwood Diana N J

机构信息

Hospital for Tropical Diseases, London WC1E 6AU, United Kingdom.

出版信息

Emerg Infect Dis. 2006 Aug;12(8):1257-9. doi: 10.3201/eid1708.050486.

DOI:10.3201/eid1708.050486
PMID:16965709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3291201/
Abstract

A 20-year (1985-2004) retrospective review of 39 patients with imported visceral leishmaniasis found that tourism to Mediterranean countries and HIV infection were associated with visceral leishmaniasis. Diagnosis was often delayed. Treatment with liposomal amphotericin B has improved prognosis. Visceral leishmaniasis should be made a reportable disease.

摘要

一项对39例输入性内脏利什曼病患者进行的为期20年（1985 - 2004年）的回顾性研究发现，前往地中海国家旅游和感染艾滋病毒与内脏利什曼病有关。诊断往往延迟。使用脂质体两性霉素B治疗改善了预后。内脏利什曼病应列为须报告的疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db3/3291201/113269de0024/05-0486-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db3/3291201/721547603f28/05-0486-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db3/3291201/113269de0024/05-0486-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db3/3291201/721547603f28/05-0486-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db3/3291201/113269de0024/05-0486-F2.jpg

相似文献

1
Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004.1985 - 2004年英国内脏利什曼病的变化模式
Emerg Infect Dis. 2006 Aug;12(8):1257-9. doi: 10.3201/eid1708.050486.
2
[Clinical signs of visceral leishmaniasis in adults: is the manner of presentation changing?].[成人内脏利什曼病的临床体征：临床表现方式是否正在改变？]
Parassitologia. 2004 Jun;46(1-2):225-6.
3
Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature.造血细胞移植中的内脏利什曼病：病例报告及文献综述
J Infect Chemother. 2018 Dec;24(12):990-994. doi: 10.1016/j.jiac.2018.05.008. Epub 2018 Aug 8.
4
Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus.脂质体两性霉素B成功治疗感染人类免疫缺陷病毒患者的耐锑内脏利什曼病。
Clin Infect Dis. 1993 Oct;17(4):625-7. doi: 10.1093/clinids/17.4.625.
5
Visceral leishmaniasis with pericarditis in an HIV-infected patient.一名感染HIV的患者患内脏利什曼病并伴有心包炎。
Scand J Infect Dis. 2002;34(2):151-3. doi: 10.1080/00365540110076921.
6
[The first case of visceral leishmaniasis in a patient with HIV infection in Russia].[俄罗斯首例HIV感染患者的内脏利什曼病]
Ter Arkh. 1997;69(11):48-50.
7
[Visceral leishmaniasis associated with human immunodeficiency virus infection].[与人类免疫缺陷病毒感染相关的内脏利什曼病]
Enferm Infecc Microbiol Clin. 2001 Aug-Sep;19(7):353-7. doi: 10.1016/s0213-005x(01)72665-1.
8
HIV-associated visceral leishmaniasis.人类免疫缺陷病毒相关内脏利什曼病
Clin Microbiol Infect. 2001 Jun;7(6):291-300. doi: 10.1046/j.1198-743x.2001.00262.x.
9
Diagnostic considerations about visceral leishmaniasis. Two case report.关于内脏利什曼病的诊断考量。两例病例报告。
Infez Med. 2002 Sep;10(3):176-8.
10
Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK.旅行者在圭亚那感染内脏利什曼病，系由 siamensis 利什曼原虫引起，英国伦敦。
Emerg Infect Dis. 2018 Jan;24(1):155-156. doi: 10.3201/eid2401.161428.

引用本文的文献

1
A Rare Case of Imported Cutaneous Leishmaniasis Caused by in the Republic of Korea, 2021.2021年，韩国一例由[未提及具体病原体]引起的输入性皮肤利什曼病罕见病例。
Trop Med Infect Dis. 2023 Apr 12;8(4):223. doi: 10.3390/tropicalmed8040223.
2
Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.2000年至2021年全球报告的人间非地方性利什曼病——一项全面综述
Pathogens. 2022 Aug 16;11(8):921. doi: 10.3390/pathogens11080921.
3
Haemophagocytic lymphohistiocytosis in adult critical care.成人重症监护中的噬血细胞性淋巴组织细胞增生症

本文引用的文献

1
Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection.口服米替福新治疗免疫功能低下患者的利什曼病：39例HIV感染患者的同情用药
Clin Infect Dis. 2004 Nov 15;39(10):1520-3. doi: 10.1086/425359. Epub 2004 Oct 18.
2
Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.HIV感染者的内脏利什曼病：临床特征及其他机会性感染
Ann Trop Med Parasitol. 2003 Oct;97 Suppl 1:99-105. doi: 10.1179/000349803225002570.
3
Leishmaniasis in Germany.
J Intensive Care Soc. 2020 Aug;21(3):256-268. doi: 10.1177/1751143719893865. Epub 2020 Jan 7.
4
A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe.一名免疫功能正常的旅行者从欧洲返回美国后，患上了罕见的内脏利什曼病。
PLoS Negl Trop Dis. 2018 Oct 4;12(10):e0006727. doi: 10.1371/journal.pntd.0006727. eCollection 2018 Oct.
5
Visceral leishmaniasis in a patient with diabetes mellitus type 2 and discrete bicytopenia.一名2型糖尿病合并轻度双细胞减少症患者的内脏利什曼病。
Clin Case Rep. 2017 Nov 28;6(1):78-81. doi: 10.1002/ccr3.1259. eCollection 2018 Jan.
6
Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis.输入性利什曼病患者治疗后特异性K39抗体反应及其持久性
Parasitol Res. 2016 Feb;115(2):761-9. doi: 10.1007/s00436-015-4801-8. Epub 2015 Oct 28.
7
Epidemiology of Imported Leishmaniasis in Italy: Implications for a European Endemic Country.意大利输入性利什曼病的流行病学：对一个欧洲地方性国家的启示
PLoS One. 2015 Jun 26;10(6):e0129418. doi: 10.1371/journal.pone.0129418. eCollection 2015.
8
Visceral leishmaniasis and immunocompromise as a risk factor for the development of visceral leishmaniasis: a changing pattern at the hospital for tropical diseases, london.内脏利什曼病与免疫功能低下作为内脏利什曼病发生的危险因素：伦敦热带病医院的变化模式
PLoS One. 2015 Apr 1;10(4):e0121418. doi: 10.1371/journal.pone.0121418. eCollection 2015.
9
Visceral Leishmaniasis in a UK Toddler following a Short Trip to a Popular Holiday Destination in Spain.一名英国幼儿在短期前往西班牙热门度假目的地后感染内脏利什曼病。
Case Rep Infect Dis. 2014;2014:537052. doi: 10.1155/2014/537052. Epub 2014 Aug 10.
10
Imported parasitic infections in Serbia.塞尔维亚的输入性寄生虫感染
Eur J Microbiol Immunol (Bp). 2011 Mar;1(1):80-5. doi: 10.1556/EuJMI.1.2011.1.10.
德国的利什曼病。
Emerg Infect Dis. 2003 Jul;9(7):872-5. doi: 10.3201/eid0907.030023.
4
Mediterranean visceral leishmaniasis in HIV-negative adults: a retrospective analysis of 64 consecutive cases (1995-2001).HIV阴性成人中的地中海内脏利什曼病：对64例连续病例（1995 - 2001年）的回顾性分析
J Antimicrob Chemother. 2003 Aug;52(2):264-8. doi: 10.1093/jac/dkg340. Epub 2003 Jul 15.
5
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.内脏利什曼病：控制、诊断和治疗的现状以及拟议的研发议程。
Lancet Infect Dis. 2002 Aug;2(8):494-501. doi: 10.1016/s1473-3099(02)00347-x.
6
The increase in risk factors for leishmaniasis worldwide.全球范围内利什曼病风险因素的增加。
Trans R Soc Trop Med Hyg. 2001 May-Jun;95(3):239-43. doi: 10.1016/s0035-9203(01)90223-8.
7
A nested-PCR-based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan.一种基于巢式聚合酶链反应的裂殖体方法，用于直接从临床样本中鉴定利什曼原虫动基体小环类别及其在巴基斯坦热带利什曼原虫流行病学研究中的应用。
J Clin Microbiol. 1998 Oct;36(10):2877-81. doi: 10.1128/JCM.36.10.2877-2881.1998.
8
Visceral leishmaniasis in Liguria, Italy.意大利利古里亚地区的内脏利什曼病
Lancet. 1998 Apr 11;351(9109):1136. doi: 10.1016/S0140-6736(05)79424-1.
9
Visceral leishmaniasis in southern Croatia.克罗地亚南部的内脏利什曼病。
Lancet. 1998 Jan 17;351(9097):188. doi: 10.1016/S0140-6736(05)78208-8.
10
Leishmania and human immunodeficiency virus coinfection: the first 10 years.利什曼原虫与人类免疫缺陷病毒合并感染：头十年
Clin Microbiol Rev. 1997 Apr;10(2):298-319. doi: 10.1128/CMR.10.2.298.